Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vintafolide in progressive lung adenocarcinoma
NCT00511485Phase 2Completed
- Sponsor
- Endocyte
- Start
- Aug 2007
- Primary completion
- Jul 2009
- Modality
- Prodrugs/Conditional Activator Small Molecules, Peptide-Drug Conjugates
01
Overview
A Phase 2 trial of vintafolide in lung adenocarcinoma, sponsored by Endocyte. Started Aug 2007; status: completed.
02
Drugs
vintafolide
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT00511485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00511485.